Research Associate, Research Scientist, Clinical Research
Listed on 2025-12-27
-
Research/Development
Research Scientist, Clinical Research, Immunology Research
Research Associate
Join to apply for the Research Associate role at Elicio Therapeutics.
Reporting to the Scientist I/II and closely working with the Senior Research Associate I/II, this individual will serve as an integral team member in the Research Department with exposure to multiple facets of research operations including program discovery and development. The Research Associate will be responsible for executing and analyzing lab‑based and small animal experiments.
Elicio (ELTX) is a growing organization based out of the Seaport area of Boston, Massachusetts with additional staff functioning in a virtual based environment from the Greater Boston area and throughout the United States.
Major Duties/Responsibilities- Executing and analyzing small animal experiments to evaluate immune responses to various antigen and adjuvant combinations (murine handling, injections, blood/organ collections, ex vivo tissue preparation and analysis)
- Executing and analyzing small animal experiments to evaluate anti‑tumor activity of immunotherapy candidates (murine handling, tumor injections and monitoring, blood/organ collections, ex vivo tissue preparation and analysis)
- Executing assays to assess mechanisms of action underlying therapeutic activity
- Maintaining detailed and accurate records, data graphing and presentation
- Communicating findings in various forums both intra‑ and interdepartmentally
- Highly productive and comfortable in a fast‑paced work environment
- Bachelor’s degree in biology or related discipline
- Murine handling techniques and injections
- Sample collection and processing: blood, spleen, lymph nodes, tumor, etc
- Experience with murine syngeneic tumor models
- Execution of ex‑vivo immuno‑assays: multi‑color flow cytometry, ELISpot/Fluoro Spot, ELISA, Luminex, etc
- Tissue culture (cell culture and aseptic technique, isolation of splenocytes or lymphocytes from murine samples)
- Hands on experience with in vitro human immune cell assays a plus
- Familiarity with pre‑clinical drug development a plus
Busy office/laboratory environment with frequent deadlines and interruptions.
TravelFrequent travel to animal facility required (within 3 miles of Elicio office).
Physical RequirementsSubject to periods of sitting or standing; vision required to monitor data.
Work LocationThis role is onsite only.
About Elicio TherapeuticsElicio Therapeutics, Inc. (Nasdaq: ELTX) is a clinical‑stage biotechnology company advancing a pipeline of novel lymph node‑targeted immunotherapies for the treatment of some of the most aggressive cancers. By combining expertise in immunology and immunotherapy, Elicio is harnessing the natural power of the immune system with the AMP technology, which allows for therapeutic payloads to be delivered directly to lymph nodes, enhancing the immune system’s cancer‑fighting capabilities.
Engineered to synchronize immunity in these highly potent sites, AMP enhances the magnitude, potency, quality and durability of the immune response to drive antitumor activity. The company’s R&D pipeline includes off‑the‑shelf therapeutic cancer immunotherapy ELI‑002, ELI‑007 and ELI‑008. For more information, visit
Elicio’s proprietary AMP platform delivers investigational immunotherapeutics directly to the lymph nodes by latching on to circulating albumin. Preclinical models demonstrate lymph node‑specific engagement drives robust and durable adaptive immune responses, potentially translating to superior clinical benefits compared to non‑targeted approaches.
CompensationBase salary $70,000 – $85,000 annually, depending on experience, education, and relevant skills. Compensation also includes an annual bonus, equity, and the company's benefits package.
NO EXTERNAL RECRUITER CALLS
Seniority levelEntry level
Employment typeFull‑time
Job functionResearch, Analyst, and Information Technology
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).